Treat Paper II as constrained drafting: every claim must trace to the disclosure (Section 10(5)), survive the Section 3 exclusions on substance rather than wording, and every amendment must stay within the originally filed matter without broadening (Section 59). Practise by drafting from granted specifications and auditing your own claims against these three statutory tests.
Why Every Paper II Task Is a Constrained Drafting Problem
The drafting tasks reward precision within statutory limits. Section 10(5) forces fair basis, Section 3 forces substantive patentability, and Section 59 forbids broadening or matter beyond the original disclosure. A strong answer satisfies all three simultaneously, not one at a time.
These constraints interact, and that interaction is where drafting errors live. A claim drafted to dodge a Section 3 exclusion by adding technical limitations only works if the specification supports those limitations; an amendment that narrows to avoid prior art only works if it stays within the originally filed matter. Treating Section 10, Section 3 and Section 59 as three independent checkboxes produces answers that pass one test while failing another.
A practical starting habit: whenever you draft or amend anything, write three marginal notes — 'fair basis check', 'Section 3 check', 'scope check' — and audit the text against each. This turns an open-ended drafting exercise into a bounded verification routine, which is exactly the discipline a drafter before the Indian Patent Office needs. It also gives you a self-assessment method you can apply to every practice question without waiting for external feedback.
Assembling a Complete Specification That Meets Section 10
Section 10 prescribes what a complete specification must contain: a full description of the invention, drawings where needed, the best method of performance, an abstract, and claims that are clear, concise and fairly based.
Draft each component to its statutory job. The description must enable the invention to be performed and must disclose the best method known to the applicant; a description that withholds the best method undermines the application regardless of how good the claims look. The abstract exists for technical information purposes — it should state the technical field and the gist of the invention briefly, not function as a mini summary of every claim. The claims must relate to a single invention or a group of inventions linked so as to form a single inventive concept.
A useful drill is reverse-engineering: take a granted specification published in the Official Journal on the IP India portal and map every claim limitation back to the paragraph of the description that supports it. When you find a limitation you cannot trace, note how the claim could have been attacked on fair-basis grounds. Doing this across several granted patents in different technical fields — mechanical, chemical, electronic — builds the instinct for how much disclosure a given claim shape actually requires, which is the judgment Section 10(5) tests.
Defending a New Chemical Form Against a Section 3(d) Objection
Section 3(d) treats new forms of a known substance as the same substance unless they differ significantly in efficacy. Drafting responses means tying the claimed form to demonstrated enhanced efficacy, not to improved physical properties alone.
Scenario: a specification discloses a crystalline form of a known kinase inhibitor, listing its X-ray diffraction peaks and noting moderately higher dissolution. The claim reads 'crystalline Form B of compound X for use in treating cancer'. The examiner objects under Section 3(d). The common drafting mistake is to amend the claim to read 'crystalline Form B of compound X exhibiting enhanced efficacy'. That inserts a bare recital without evidentiary support — Section 3(d) asks whether the new form demonstrates significantly enhanced efficacy, and the Supreme Court in Novartis AG v. Union of India held that improved bioavailability alone does not establish the enhanced therapeutic efficacy Section 3(d) requires.
The better decision is to go back to the description and ask what the data actually shows. If the specification links the dissolution improvement to a measurable therapeutic outcome, draft the efficacy tie into the claim with the specific, disclosed functional language. If it does not, an honest narrowing — claiming the form per se only where you can show a significant efficacy difference, or repositioning around what the data supports — beats an unsupported efficacy recital, which risks fair-basis and sufficiency problems under Section 10 on top of the Section 3(d) objection and burns examination rounds without resolving the core issue.
Reframing Software and Business Claims Under Section 3(k)
Section 3(k) excludes mathematical methods, business methods, computer programs per se and algorithms. Objections turn on substance: relabelling a method as a 'system' changes nothing unless genuinely technical, disclosed features carry the claim.
Scenario: a specification describes a method of allocating delivery slots for drivers — receiving demand data, computing optimal routes, displaying results — all 'executed by a computer system'. An objection under Section 3(k) follows. The typical wrong move is retitling the claim as a 'system for optimizing delivery' while keeping the same business-logic steps. Section 3(k) is applied to the substance of what is claimed, so a cosmetic change of claim category leaves the excluded subject matter untouched.
The better decision starts in the specification. If the description discloses no technical implementation detail, no amendment can rescue the claim — adding hardware language would be new matter beyond the original disclosure and would fail fair basis. If the description does explain how the computation interacts with, say, positioning hardware to achieve a defined technical result, draft an apparatus or arrangement claim built from those disclosed technical elements. Why it matters: Section 3(k) drafting is a specification problem as much as a claim problem, and the table below shows how the principal exclusions shape the drafting decision differently.
| Provision | What it targets | Drafting implication | Boundary of the workaround |
|---|---|---|---|
| Section 3(d) | New forms of known substances without significant efficacy enhancement | Tie the claimed form to disclosed efficacy data, not physical-property recitals alone | Bioavailability or stability gains alone do not establish enhanced therapeutic efficacy |
| Section 3(e) | Mere aggregation or arrangement of known components each functioning independently | Show how the combination produces a new or improved result, not just juxtaposition | The synergy must be derivable from the specification, not asserted in the claim |
| Section 3(i) | Methods of medical, surgical, curative or prophylactic treatment of humans and animals | Claim the product, apparatus or substance instead of the treatment method | Product claims for the same purpose remain available; the method itself stays excluded |
| Section 3(k) | Mathematical methods, business methods, algorithms, computer programs per se | Ground the claim in disclosed technical features and a technical effect | No rescue where the description contains only business logic; relabelling is not substance |
Amending Claims Without Crossing the Section 59 Line
Section 59 prohibits any amendment of a claim that broadens its scope, and confines amendments by way of disclaimer, correction or explanation, with no new matter beyond the original specification. Narrowing must therefore be both surgical and supported.
Work a small example. Original claim: 'a valve made of steel'. Faced with prior art on valves generally, the applicant cannot amend to 'a valve' — that broadens. Narrowing to 'a valve made of stainless steel' is permissible only if the original specification actually discloses stainless steel as an embodiment; if it never mentioned any specific steel, even the narrowing amendment introduces matter beyond the original disclosure and fails. The two tests to run on every amendment are therefore: does the scope shrink, and does the new wording find a home in the originally filed description?
This matters most when responding to objections, because the narrowing that avoids one prior-art reference can drift into unsupported territory if rushed. Build the habit of redrafting the amended claim first, then quoting the supporting description passage next to each new limitation, then only filing. An amendment that shrinks scope but rests on matter never originally disclosed invites its own objections and can jeopardize the application's foundation, which is a far worse outcome than a slower, fully supported narrowing. Keep in mind too that leave to amend and the Controller's supervision of the process sit under Section 57 — the amendment framework in Sections 57 and 59 together — so an answer should frame who seeks leave, by what procedure, and within what limits.
Choosing the Right Procedure: Divisionals, Publication and Opposition Basics
Paper II drafting sits inside Indian procedure: divisionals arise only from a plurality of inventions (Section 16), publication under Section 11A opens the application to pre-grant opposition (Section 25(1)), and post-grant opposition has different standing.
Distinguish the divisional mechanism clearly. Under Section 16, an applicant may file a divisional application if the original application relates to more than one invention; the divisional is treated as if filed on the parent's date, carrying its priority position. India does not provide a continuation-style route for pursuing broader or parallel claims on the same invention — so if a drafting answer requires splitting subject matter, the split must be justified by genuinely distinct inventions in the original disclosure, not by strategic claim-stacking.
Know who can oppose, because standing differs. Pre-grant opposition under Section 25(1) may be filed by any person after the application is published and before grant, on grounds including anticipation, obviousness, non-patentable subject matter, insufficiency and failure to disclose information about corresponding foreign applications required by Section 8. Post-grant opposition under Section 25(2) is available only to a 'person interested' and operates after grant. When drafting responses, identify which regime you are in first: the available grounds, the timing and the evidence posture all follow from that classification.
A Drafting Drill With a Self-Check Rubric and a Four-Week Sequence
Practise with a timed claim-drafting drill on a short paper disclosure, then audit the draft with a fixed rubric. Sequence four weeks around the Act's drafting provisions, journal drafting, amendment drills and full timed sets.
The drill: take a brief invented disclosure — for example, a solar-powered water level indicator with a float sensor, a housing, a display and a low-power sleep mode — and in 45 minutes draft one independent apparatus claim, two dependent claims and a short abstract. Expect two failure modes to check for: omitting an essential component so the claim fails to define the invention, and loading the independent claim with features the stated problem does not require. Both are visible only against the disclosure, which is why the rubric below anchors every check to the source text.
An adaptable four-week sequence: Week 1, read the drafting-relevant provisions — Sections 2, 3, 8, 10, 11A, 14 to 16, 25, 57 and 59 — alongside the Form 2 template in the Rules' schedules. Week 2, draft claims from granted specifications in the Official Journal on ipindia.gov.in and compare your claims with the granted ones. Week 3, run amendment drills: take a claim, apply a narrowing amendment, and defend it against both the Section 59 broadening test and the fair-basis test. Week 4, complete a full timed drafting set and map each objection you simulate to the correct opposition ground and standing.
- Traceability: every limitation in the independent claim is supported by a specific passage in the description.
- Essential features: the independent claim recites all components the stated technical problem requires, and nothing beyond them.
- Exclusion clearance: the claim's substance, not just its label, survives the relevant Section 3 provision.
- Abstract fit: the abstract states the technical field and the gist of the invention, without restating the claims wholesale.
- Scope safety: no wording could be read as broader than the original disclosure, and any amendment passes both limbs of Section 59 — no broadening and no matter beyond the original specification.
- Structure: claims are numbered, dependencies are unambiguous, and, per the provisos to Section 10(5) in the Act itself, a multiple dependent claim does not serve as the basis for any other multiple dependent claim.
References and further reading
Use these references to explore the concepts and check the latest information from the relevant organizations.